Analyst sees little movement from FDA on regulating CBD – MarketWatch

/
/

The U.S. Food and Drug Administration (FDA) is not expected to move quickly on regulating cannabinoids (CBD) from hemp, Cowen analyst Harrison …

  • Facebook
  • Twitter
  • Google+
  • Linkedin
  • Pinterest
This div height required for enabling the sticky sidebar